Clinical Trials Browser

Phase 3 × INDUSTRY × Chemotherapy-induced Peripheral Neuropathy (CIPN) × Clear all

NCT06994507 2025-08-06

GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer

Phase 3 Recruiting

Chemotherapy-induced Peripheral Neuropathy (CIPN)